Evidence map›Paper›PMID 17433256›Full record

ArticleBiochemical and biophysical research communications2007

Prolactin upregulates its receptors and inhibits lipolysis and leptin release in male rat adipose tissue.

Terry D Brandebourg, Jenna L Bown, Nira Ben-Jonathan

Open access · greenAbstract read
In one paragraph

Article in Biochemical and biophysical research communications, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 56 citations in OpenAlex.

  1. Review
  2. Effects of Prolactin Inhibition on Lipid Metabolism in Goats.Animals : an open access journal from MDPI · 2024
    Article
  3. Review
  4. The beneficial metabolic actions of prolactin.Frontiers in endocrinology · 2022
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Neuroendocrine Regulation of Metabolism.Journal of neuroendocrinology · 2016
    Review
  11. Article
  12. Article
  13. Article
  14. The role of prolactin in andrology: what is new?Reviews in endocrine & metabolic disorders · 2015
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Terry D BrandebourgDepartment of Cell and Cancer Biology, University of Cincinnati College of Medicine, 3125 Eden Avenue, Cincinnati, OH 45267-0521, USA.
Jenna L Bown
Nira Ben-Jonathan
University of Cincinnati Medical Center · US

Funding

Prolactin as a Growth Factor in Breast CancerR01CA096613 · NCI · UNIVERSITY OF CINCINNATI · PI BEN-JONATHAN, NIRA · 2004 to 2013
$2.7M
GENETIC ANALYSIS OF MULTIDRUG RESISTANCE GENESZ01BC005725 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI DEAN, MICHAEL · 1996 to 2008
$1.9M
TRAINING IN DEVELOPMENTAL AND PERINATAL ENDOCRINOLOGYT32HD007463 · NICHD · CINCINNATI CHILDRENS HOSP MED CTR · PI HANDWERGER, STUART · 1994 to 2010
$1.5M
Xenoestrogens: Genomic and Non-genomic MechanismsR01ES012212 · NIEHS · UNIVERSITY OF CINCINNATI · PI BEN-JONATHAN, NIRA · 2003 to 2006
$1.1M
Intramural NIH HHS Z01 BC005725NCI NIH HHS CA096613NCI NIH HHS R01 CA096613NICHD NIH HHS T32 HD007463NICHD NIH HHS T32 HD07463NIEHS NIH HHS ES012212NIEHS NIH HHS R01 ES012212
6 · The paper itself

Abstract

Prolactin (PRL) is recognized as a metabolic regulator during lactation, but little information exists on its actions in male adipose tissue. We examined whether PRL affects the expression of its receptors (PRLR), lipolysis, and adipokine secretion in male rats. Both long and short PRLR isoforms were induced 40-50-fold during differentiation of epididymal preadipocytes, with a 10-fold higher expression of the long isoform. PRL upregulated both isoforms before and after differentiation. PRL suppressed lipolysis in epididymal explants and mature adipocytes in a dose- and time-dependent manner, which was reversed by a Jak2 inhibitor. PRL also inhibited leptin, but not adiponectin, release. We conclude that PRL inhibits lipolysis and leptin release by acting directly on adipocytes via interaction with either of its receptors and activation of a Jak2-dependent signaling pathway(s). This is the first demonstration of substantial effects of PRL on male adipocytes.

Indexed as

AdipocytesAdipogenesisAdipose TissueAnimalsCells, CulturedDose-Response Relationship, DrugFemaleLeptinLipolysisMaleProlactinRatsRats, Sprague-DawleyReceptors, ProlactinSignal TransductionUp-RegulationLeptinProlactinReceptors, Prolactin

Identifiers

PMID17433256
PMCPMC1885988
OpenAlexW2033385793

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.